Clinical Trial Update: Mendelian Reverse Cholesterol Transport Study [NA]

View source ↗

Summary

This clinical trial update announces that the Mendelian reverse cholesterol transport study sponsored by the University of Pennsylvania has been terminated. It …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholesteryl Ester Transfer Protein Deficiency
• Lcat Deficiency
• Tangier Disease

Snippet

Sponsor: University of Pennsylvania | Conditions: Cholesterol, HDL, Lipid Metabolism, Inborn Errors | NA | Status: TERMINATED